Skip to main content
SpringerLink
Log in

Nutrition and Chronic Kidney Disease

  • Chapter
  • First Online:
Handbook of Clinical Nutrition and Aging

Part of the book series: Nutrition and Health ((NH))

Abstract

Dietary and lifestyle interventions could help reduce the burden of chronic kidney disease (CKD) in the United States. This chapter presents an overview of the effects of diet and nutritional status on the development and progression of CKD. Based on current research data, it aims to address the following problems: (1) the role of diet (salt and protein) and obesity on development and progression of CKD (2) the nutritional issues, especially obesity and malnutrition, that might be unique to uremia in advanced CKD (3) calcium-phosphorus status, parathyroid hormone, and vascular calcification in CKD. The chapter also presents a summary of diet recommendations for different levels of renal function. Specific dietary guidance regarding protein level and intakes of sodium, phosphorus, potassium, and fluids must be carefully individualized appropriately for the level of renal function.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. May RC, Kelly RA, Mitch WE. Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. J Clin Invest. 1987;79:1099–103.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.

    Article  CAS  PubMed  Google Scholar 

  3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.

    Article  CAS  PubMed  Google Scholar 

  4. Beddhu S, Allen-Brady K, Cheung AK, Horne BD, Bair T, Muhlestein JB, et al. Impact of renal failure on the risk of myocardial infarction and death. Kidney Int. 2002;62:1776–83.

    Article  PubMed  Google Scholar 

  5. May RC, Bailey JL, Mitch WE, Masud T, England BK. Glucocorticoids and acidosis stimulate protein and amino acid catabolism in vivo. Kidney Int. 1996;49:679–83.

    Article  CAS  PubMed  Google Scholar 

  6. Melander O, von Wowern F, Frandsen E, Burri P, Willsteen G, Aurell M, et al. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma. J Hypertens. 2007;25:619–27.

    Article  CAS  PubMed  Google Scholar 

  7. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension. 2005;46:308–12.

    Article  CAS  PubMed  Google Scholar 

  8. Fodor JG, Whitmore B, Leenen F, Larochelle P. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ. 1999;160:S29–34.

    CAS  PubMed Central  PubMed  Google Scholar 

  9. Krikken JA, Lely AT, Bakker SJ, Navis G. The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int. 2007;71:260–5.

    Article  CAS  PubMed  Google Scholar 

  10. Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR, et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA. 2007;297:969–77.

    Article  CAS  PubMed  Google Scholar 

  11. Frank H, Graf J, Amann-Gassner U, Bratke R, Daniel H, Heemann U, et al. Effect of short-term high-protein compared with normal-protein diets on renal hemodynamics and associated variables in healthy young men. Am J Clin Nutr. 2009;90:1509–16.

    Article  CAS  PubMed  Google Scholar 

  12. Skov AR, Toubro S, Bulow J, Krabbe K, Parving HH, Astrup A. Changes in renal function during weight loss induced by high vs low-protein low-fat diets in overweight subjects. Int J Obes Relat Metab Disord. 1999;23:1170–7.

    Article  CAS  PubMed  Google Scholar 

  13. Walker JD, Bending JJ, Dodds RA, Mattock MB, Murrells TJ, Keen H, et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet. 1989;2:1411–5.

    Article  CAS  PubMed  Google Scholar 

  14. Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1991;324:78–84.

    Article  CAS  PubMed  Google Scholar 

  15. Levey AS, Greene T, Sarnak MJ, Wang X, Beck GJ, Kusek JW, et al. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis. 2006;48:879–88.

    Article  CAS  PubMed  Google Scholar 

  16. Menon V, Kopple JD, Wang X, Beck GJ, Collins AJ, Kusek JW, et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis. 2009;53:208–17.

    Article  CAS  PubMed  Google Scholar 

  17. Cianciaruso B, Pota A, Bellizzi V, Di Giuseppe D, Di Micco L, Minutolo R, et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. Am J Kidney Dis. 2009;54:1052–61.

    Article  CAS  PubMed  Google Scholar 

  18. Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarod K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis. 2006;47:396–405.

    Article  PubMed  Google Scholar 

  19. Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis. 2005;46:587–94.

    Article  PubMed  Google Scholar 

  20. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871–80.

    Article  PubMed  Google Scholar 

  21. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21–8.

    Article  PubMed  Google Scholar 

  22. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol. 2003;14:1480–6.

    Article  PubMed  Google Scholar 

  23. Vogel JA, Franklin BA, Zalesin KC, Trivax JE, Krause KR, Chengelis DL, et al. Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. Am J Cardiol. 2007;99:222–6.

    Article  PubMed  Google Scholar 

  24. Navarro-Diaz M, Serra A, Romero R, Bonet J, Bayés B, Homs M, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol. 2006;17:S213–7.

    Article  PubMed  Google Scholar 

  25. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–40.

    Article  PubMed  Google Scholar 

  26. Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation. 1999;99:2221–2.

    CAS  PubMed  Google Scholar 

  27. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation. 1997;96:3042–7.

    Article  CAS  PubMed  Google Scholar 

  28. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J. 1999;13:1231–8.

    CAS  PubMed  Google Scholar 

  29. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271:665–8.

    Article  CAS  PubMed  Google Scholar 

  30. Nakajima J, Mogi M, Kage T, Chino T, Harada M. Hypertriglyceridemia associated with tumor necrosis factor-alpha in hamster cheek-pouch carcinogenesis. J Dent Res. 1995;74:1558–63.

    Article  CAS  PubMed  Google Scholar 

  31. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003;107:671–4.

    Article  CAS  PubMed  Google Scholar 

  32. Quehenberger P, Exner M, Sunder-Plassmann R, Ruzicka K, Bieglmayer C, Endler G, et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res. 2002;90:711–8.

    Article  CAS  PubMed  Google Scholar 

  33. Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care. 2005;28:2181–6.

    Article  CAS  PubMed  Google Scholar 

  34. Stephens JM, Pekala PH. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem. 1991;266:21839–45.

    CAS  PubMed  Google Scholar 

  35. Tham DM, Martin-McNulty B, Wang YX, Wilson DW, Vergona R, Sullivan ME, et al. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol Genomics. 2002;11:21–30.

    CAS  PubMed  Google Scholar 

  36. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation. 2003;108:736–40.

    Article  CAS  PubMed  Google Scholar 

  37. von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care. 2004;27:2925–9.

    Article  Google Scholar 

  38. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin—a key adipokine in the metabolic syndrome. Diabetes Obes Metab. 2006;8:264–80.

    Article  CAS  PubMed  Google Scholar 

  40. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002;105:804–9.

    Article  CAS  PubMed  Google Scholar 

  41. MacLaughlin HL, Cook SA, Kariyawasam D, Roseke M, van Niekerk M, Macdougall IC. Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up. Am J Kidney Dis. 2010;55:69–76.

    Article  PubMed  Google Scholar 

  42. MacLaughlin HL, Sarafidis PA, Greenwood SA, Campbell KL, Hall WL, Macdougall IC. Compliance with a structured weight loss program is associated with reduced systolic blood pressure in obese patients with chronic kidney disease. Am J Hypertens. 2012;25:1024–9.

    Article  PubMed  Google Scholar 

  43. Johansen KL, Young B, Kaysen GA, Chertow GM. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr. 2004;80:324–32.

    CAS  PubMed  Google Scholar 

  44. Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY, et al. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int. 2004;65:597–605.

    Article  PubMed  Google Scholar 

  45. Aoyagi T, Naka H, Miyaji K, Hayakawa K, Ishikawa H, Hata M. Body mass index for chronic hemodialysis patients: stable hemodialysis and mortality. Int J Urol. 2001;8:S71–5.

    Article  CAS  PubMed  Google Scholar 

  46. Beddhu S, Pappas LM, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol. 2003;14:2366–72.

    Article  PubMed  Google Scholar 

  47. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81:543–54.

    CAS  PubMed  Google Scholar 

  48. Kopple JD. Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J. 1997;43:246–50.

    CAS  PubMed  Google Scholar 

  49. Kutner NG, Zhang R. Body mass index as a predictor of continued survival in older chronic dialysis patients. Int Urol Nephrol. 2001;32:441–8.

    Article  CAS  PubMed  Google Scholar 

  50. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW. Body mass index and mortality in ‘healthier’ as compared with ‘sicker’ haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2001;16:2386–94.

    Article  CAS  PubMed  Google Scholar 

  51. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis. 1998;31:997–1006.

    Article  CAS  PubMed  Google Scholar 

  52. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003;42:864–81.

    Article  PubMed  Google Scholar 

  53. Nishizawa Y, Shoji T, Ishimura E, Inaba M, Morii H. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis. 2001;38:S4–7.

    Article  CAS  PubMed  Google Scholar 

  54. Yamauchi T, Kuno T, Takada H, Nagura Y, Kanmatsuse K, Takahashi S. The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dialysis Transplant. 2003;18:1842–7.

    Article  Google Scholar 

  55. Beddhu S, Pappas LM, Ramkumar N, Samore MH. Malnutrition and atherosclerosis in dialysis patients. J Am Soc Nephrol. 2004;15:733–42.

    Article  CAS  PubMed  Google Scholar 

  56. Axelsson J, Rashid Qureshi A, Suliman ME, Honda H, Pecoits-Filho R, Heimbürger O, et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr. 2004;80:1222–9.

    CAS  PubMed  Google Scholar 

  57. Axelsson J, Qureshi AR, Heimburger O, Lindholm B, Stenvinkel P, Barany P. Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD. Am J Kidney Dis. 2005;46:628–34.

    Article  CAS  PubMed  Google Scholar 

  58. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–83.

    Article  CAS  PubMed  Google Scholar 

  59. Stompor T, Pasowicz M, Sullowicz W, Dembińska-Kieć A, Janda K, Wójcik K, et al. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis. 2003;41:203–11.

    Article  PubMed  Google Scholar 

  60. Kwan BC, Beddhu S. A story half untold: adiposity, adipokines and outcomes in dialysis population. Semin Dial. 2007;20:493–7.

    Article  PubMed  Google Scholar 

  61. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000;35:S1–140.

    Google Scholar 

  62. Mitch WE. Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest. 2002;110:437–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  63. Hara Y, May RC, Kelly RA, Mitch WE. Acidosis, not azotemia, stimulates branched-chain, amino acid catabolism in uremic rats. Kidney Int. 1987;32:808–14.

    Article  CAS  PubMed  Google Scholar 

  64. Goodman MN. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol. 1991;260:E727–30.

    CAS  PubMed  Google Scholar 

  65. Goldberg AL, Kettelhut IC, Furuno K, Fagan JM, Baracos V. Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines. J Clin Invest. 1988;81:1378–83.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  66. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med. 1996;335:1897–905.

    Article  CAS  PubMed  Google Scholar 

  67. Ahuja TS, Mitch WE. The evidence against malnutrition as a prominent problem for chronic dialysis patients. Semin Dial. 2004;17:427–31.

    Article  PubMed  Google Scholar 

  68. Pickering WP, Price SR, Bircher G, Marinovic AC, Mitch WE, Walls J. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int. 2002;61:1286–92.

    Article  CAS  PubMed  Google Scholar 

  69. Pupim LB, Flakoll PJ, Brouillette JR, Levenhagen DK, Hakim RM, Ikizler TA. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest. 2002;110:483–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  70. Ikizler TA, Pupim LB, Brouillette JR, Levenhagen DK, Farmer K, Hakim RM, et al. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab. 2002;282:E107–16.

    CAS  PubMed  Google Scholar 

  71. Kaysen GA, Greene T, Daugirdas JT, Kimmel PL, Schulman GW, Toto RD, et al. Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients. Am J Kidney Dis. 2003;42:1200–11.

    Article  CAS  PubMed  Google Scholar 

  72. Kaizu Y, Ohkawa S, Odamaki M, Ikegaya N, Hibi I, Miyaji K, et al. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients. Am J Kidney Dis. 2003;42:295–302.

    Article  CAS  PubMed  Google Scholar 

  73. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38:1251–63.

    Article  CAS  PubMed  Google Scholar 

  74. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–911.

    Article  CAS  PubMed  Google Scholar 

  75. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15:953–60.

    Article  CAS  PubMed  Google Scholar 

  76. Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant. 2004;19:1489–96.

    Article  PubMed  Google Scholar 

  77. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001;12:2131–8.

    CAS  PubMed  Google Scholar 

  78. Savory J, Bertholf RL, Wills MR. Aluminium toxicity in chronic renal insufficiency. Clin Endocrinol Metab. 1985;14:681–702.

    Article  CAS  PubMed  Google Scholar 

  79. Malluche HH. Aluminium and bone disease in chronic renal failure. Nephrol Dial Transplant. 2002;17 Suppl 2:21–4.

    Article  CAS  PubMed  Google Scholar 

  80. Delmez JA, Slatopolsky E. Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis. 1992;19:303–17.

    Article  CAS  PubMed  Google Scholar 

  81. Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62:245–52.

    Article  CAS  PubMed  Google Scholar 

  82. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68:1815–24.

    Article  CAS  PubMed  Google Scholar 

  83. Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, et al. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int. 2007;72:1130–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, University of Utah, Salt Lake City, UT, USA

    Xiaorui Chen M.S.

  2. Medical Service, Salt Lake Veterans Affairs Healthcare System, Salt Lake City, UT, USA

    Srinivasan Beddhu M.D.

  3. Division of Nephrology & Hypertension, University of Utah School of Medicine, Salt Lake City, UT, USA

    Srinivasan Beddhu M.D.

Authors
  1. Xiaorui Chen M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Srinivasan Beddhu M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaorui Chen M.S. .

Editor information

Editors and Affiliations

  1. Geriatric Research, Education, and Clinical Center, Department of Medicine, Durham VA Medical Center, Duke University Medical Center, Durham, North Carolina, USA

    Connie Watkins Bales

  2. Departments of Medicine and Health Care Organization and Policy Translational Nutrition and Aging Program, University of Alabama at Birmingham, Birmingham, Alabama, USA

    Julie L. Locher

  3. Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA

    Edward Saltzman

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Chen, X., Beddhu, S. (2015). Nutrition and Chronic Kidney Disease. In: Bales, C., Locher, J., Saltzman, E. (eds) Handbook of Clinical Nutrition and Aging. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1929-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1929-1_16

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-1928-4

  • Online ISBN: 978-1-4939-1929-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation